Champions Oncology (CSBR) Change in Cash (2010 - 2026)

Champions Oncology's Change in Cash history runs 17 years deep, the most recent figure standing at -$2.3 million for Q2 2026.

• In Q2 2026, Change in Cash fell 134.25% year-over-year to -$2.3 million; the TTM figure through Apr 2026 stood at -$4.9 million (down 168.55% YoY), while the FY2026 annual figure was -$4.9 million, down 168.55% from the prior year.
• Change in Cash for Q2 2026 stood at -$2.3 million, down from -$1.4 million in the prior quarter.
• The five-year high for Change in Cash was $6.6 million in Q2 2025, with the low at -$5.2 million in Q3 2023.
• The 5-year median for Change in Cash is $68000.0 (2024), against an average of $5055.6.
• Peak annual rise in Change in Cash reached 455.84% in 2025, while the deepest fall reached 1210.87% in 2025.
• Champions Oncology's Change in Cash stood at $2.8 million in 2022, then plunged by 76.73% to $644000.0 in 2023, then plunged by 121.43% to -$138000.0 in 2024, then sank by 1210.87% to -$1.8 million in 2025, then dropped by 24.65% to -$2.3 million in 2026.
• Business Quant data shows CSBR's Change in Cash at -$2.3 million in Q2 2026, -$1.4 million in Q1 2026, and -$1.8 million in Q4 2025.